Ana is a molecular biologist with a passion for discovery and communication. As a science writer, she looks for connecting the public, in particular patients and healthcare providers, with clear and quality information about the latest medical advances. Ana holds a Ph.D. in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in infectious diseases, epigenetics, and gene expression.
Regular aerobic and strength exercises of moderate intensity done over a relatively short period of time can improve the fitness and decrease the body fat of patients with inflammatory bowel ... Read more
An experimental cell therapy for Crohn’s disease that involves taking the patient’s white blood cells, restoring their proper functioning in the lab, and giving them back to the patient, has ... Read more
Pliant Therapeutics is starting a multi-year research collaboration with Cleveland Clinic to speed the discovery of new druggable targets for gastrointestinal fibrosis, a common gut complication in patients with inflammatory ... Read more
The Lindgren score is the best for predicting the response to intravenous steroid therapy and the need for rescue therapy or bowel surgery in patients hospitalized with acute severe ulcerative ... Read more
Crohn’s and Colitis Canada has awarded $2.7 million in grants to support nine Canadian researchers studying inflammatory bowel disease (IBD). The grants include seven Grants-in-Aid of Research, intended to advance prevention, ... Read more
People with inflammatory bowel disease (IBD) appear to have an increased risk of herpes zoster infection (shingles), and Canadian researchers warn that low vaccination rates have been insufficient to reduce ... Read more
A preclinical study found that Cyxone’s investigational T20K therapy was able to reduce the immune system’s activity in an animal model of inflammatory bowel disease (IBD), showing promise as a treatment for the ... Read more